Drug name - Fenoglide

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8124125 SALIX Solid dosage form comprising a fibrate Oct, 2024

(2 years from now)

US8481078 SALIX Solid dosage form comprising a fibrate Oct, 2024

(2 years from now)

US9173847 SALIX Tablet comprising a fibrate Oct, 2024

(2 years from now)

US7658944 SALIX Solid dosage form comprising a fibrate Dec, 2024

(2 years from now)

Drugs and Companies using FENOFIBRATE ingredient

Treatment: For reducing total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides, and treating hypertriglyceridemia; Use of fenofibrate for reducing elevated total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
40MG TABLET;ORAL Prescription
120MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.